The MHRA Papers - Part 2a

and

Jan 03, 2025

∙ Paid

Before continuing our review of the minutes of meetings of the MHRA’s Commission On Human Medicines (CHM) COVID-19 Vaccines Benefit Risk Expert Working Group, we need to make you aware of some of the background to our discussions.

As you know, in this series and our Comirnaty series, we have tried to piece together the regulatory story from multiple so…

Trust the Evidence